Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. Australia
  4. Australian Stock Exchange
  5. Resonance Health Limited
  6. News
  7. Summary
    RHT   AU000000RHT2

RESONANCE HEALTH LIMITED

(RHT)
  Report
SummaryChartsNewsCalendarCompanyFinancials 
SummaryMost relevantAll NewsOther languagesPress ReleasesOfficial PublicationsSector news

Resonance Health Limited Reports Earnings Results for the Full Year Ended June 30, 2021

08/29/2021 | 06:12pm EDT

Resonance Health Limited announced earnings results for the full year ended June 30, 2021. For the full year, the company announced sales was AUD 3.778 million compared to AUD 3.668 million a year ago. Net income was AUD 585,858 compared to net loss of AUD 715,076 a year ago. Basic earnings per share from continuing operations was 0.13 cents compared to basic loss per share from continuing operations of 0.17 cents a year ago.


© S&P Capital IQ 2021
All news about RESONANCE HEALTH LIMITED
10/12Resonance Health Ltd Announces Development of Newest AI Medical Device, LiverSmart
CI
09/23EASL DIGITAL #NAFLDSUMMIT 2021 : Resonance Health presents, HepaFat-AI results equivalent ..
PU
09/21RESONANCE HEALTH : Completes Animal Dosing Study for Liver Disease Therapy Compound
MT
09/21Resonance Health Ltd announces R&D Molecular Medicine ASON Project Results of Dosing St..
CI
08/29Resonance Health Limited Reports Earnings Results for the Full Year Ended June 30, 2021
CI
07/27RESONANCE HEALTH : Appointment of GM - Global Sales & Marketing
PU
06/27Resonance Health Ltd Announces Mitchell Wells as Managing Director, Effective 2 July 20..
CI
06/17RESONANCE HEALTH : News - June 2021
PU
06/03Resonance Health Limited Announces Resignation of Alison Law as CEO
CI
06/03Resonance Health Limited Announces Management Changes
CI
More news
Financials
Sales 2021 3,78 M 2,82 M 2,82 M
Net income 2021 0,59 M 0,44 M 0,44 M
Net cash 2021 8,80 M 6,57 M 6,57 M
P/E ratio 2021 119x
Yield 2021 -
Capitalization 53,0 M 39,6 M 39,6 M
EV / Sales 2020 16,3x
EV / Sales 2021 16,6x
Nbr of Employees -
Free-Float 64,6%
Chart RESONANCE HEALTH LIMITED
Duration : Period :
Resonance Health Limited Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends RESONANCE HEALTH LIMITED
Short TermMid-TermLong Term
TrendsBullishBearishBearish
Income Statement Evolution
Managers and Directors
Mitchell Wells Chief Executive Officer, MD & Director
Nick Allan Chief Financial Officer & Secretary
Martin Blake Independent Non-Executive Chairman
Wenjie Pang Manager-Technical & Research
Sherif Boulos Manager-Clinical Research
Sector and Competitors
1st jan.Capi. (M$)
RESONANCE HEALTH LIMITED-52.08%41
THERMO FISHER SCIENTIFIC30.02%239 360
DANAHER CORPORATION41.72%221 837
INTUITIVE SURGICAL, INC.25.24%121 328
SIEMENS HEALTHINEERS AG40.64%76 589
EDWARDS LIFESCIENCES CORPORATION26.71%72 144